Stock A263050 EUTILEX.CO.,LTD
Add to a list
To use this feature you must be a member
Log inSign up

Funds and ETFs Eutilex.Co.,Ltd

Equities

A263050

KR7263050007

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-05-30 pm EDT 		5-day change 1st Jan Change
2,105 KRW -0.24% Intraday chart for Eutilex.Co.,Ltd +1.94% -37.72%
May. 16 Eutilex.Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Mar. 21 Eutilex.Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Company Profile

Eutilex Co., Ltd. is a Korea-based company mainly engaged in the production and sale of immunotherapy products. Major products include anticancer T cell therapies and antibody therapies.
Sector
Pharmaceuticals
Calendar
2024-08-12 - Q2 2024 Earnings Release (Projected)
More about the company

Income Statement Evolution

More financial data

Sector Biopharmaceuticals

1st Jan change Capi.
EUTILEX.CO.,LTD Stock Eutilex.Co.,Ltd
-37.72% 56.01M
CSL LIMITED Stock CSL Limited
-2.29% 89.87B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
-3.95% 37.57B
BIOGEN INC. Stock Biogen Inc.
-13.07% 32.75B
UCB Stock UCB
+63.05% 26.47B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-22.14% 14.25B
INCYTE CORPORATION Stock Incyte Corporation
-7.96% 12.99B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-9.33% 11.93B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-46.33% 10.84B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
+5.77% 9.11B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. A263050 Stock
  4. Funds and ETFs Eutilex.Co.,Ltd